Unknown

Dataset Information

0

Allosteric Binders of ACE2 Are Promising Anti-SARS-CoV-2 Agents.


ABSTRACT: The COVID-19 pandemic has had enormous health, economic, and social consequences. Vaccines have been successful in reducing rates of infection and hospitalization, but there is still a need for acute treatment of the disease. We investigate whether compounds that bind the human angiotensin-converting enzyme 2 (ACE2) protein can decrease SARS-CoV-2 replication without impacting ACE2's natural enzymatic function. Initial screening of a diversity library resulted in hit compounds active in an ACE2-binding assay, which showed little inhibition of ACE2 enzymatic activity (116 actives, success rate ∼4%), suggesting they were allosteric binders. Subsequent application of in silico techniques boosted success rates to ∼14% and resulted in 73 novel confirmed ACE2 binders with K d values as low as 6 nM. A subsequent SARS-CoV-2 assay revealed that five of these compounds inhibit the viral life cycle in human cells. Further effort is required to completely elucidate the antiviral mechanism of these ACE2-binders, but they present a valuable starting point for both the development of acute treatments for COVID-19 and research into the host-directed therapy.

SUBMITTER: Hochuli JE 

PROVIDER: S-EPMC9236207 | biostudies-literature | 2022 Jul

REPOSITORIES: biostudies-literature

altmetric image

Publications


The COVID-19 pandemic has had enormous health, economic, and social consequences. Vaccines have been successful in reducing rates of infection and hospitalization, but there is still a need for acute treatment of the disease. We investigate whether compounds that bind the human angiotensin-converting enzyme 2 (ACE2) protein can decrease SARS-CoV-2 replication without impacting ACE2's natural enzymatic function. Initial screening of a diversity library resulted in hit compounds active in an ACE2-  ...[more]

Similar Datasets

| S-EPMC8936107 | biostudies-literature
| S-EPMC7932696 | biostudies-literature
| EMPIAR-11181 | biostudies-other
2021-08-09 | PXD023138 | Pride
| S-EPMC9356625 | biostudies-literature
| S-EPMC8329052 | biostudies-literature
| S-SCDT-10_15252-EMBR_202256374 | biostudies-other
| S-BSST649 | biostudies-other
| S-EPMC9880710 | biostudies-literature
| EMPIAR-11180 | biostudies-other